PharmaShots | Incisive News in 3 Shots

Subscribe Now

Febrile neutropenia

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

November 5, 2019

Coherus Biosciences' Udenyca (Pegfilgrastim Biosimilar) Receives EU Marketing Approval for Febrile Neutropenia

Coherus Biosciences' Udenyca (Pegfilgrastim Biosimilar) Receives EU Marketing Approval for Febrile Neutropenia

September 26, 2018

Sandoz's Biosimilar Pegfilgrastim Receives CHMP Approval for Febrile Neutropenia

Sandoz's Biosimilar Pegfilgrastim Receives CHMP Approval for Febrile Neutropenia

September 21, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us